News
Idifarma appoints new head of site
IDIFARMA, a Spanish contract development and manufacturing organisation (CDMO) specialising in niche and highly potent products, has announced the appointment of Alfredo Gómez as its head of site.
In his new role Alfredo Gómez will be responsible for ensuring the...
News
Coronavirus Vaccine: Cipla’s remdesivir Cipremi launched in India, lowest priced drug for COVID-19
Pharma major Cipla said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month. The company, however, did...
News
1 of every 20 air cargo, carried throughout the world, rises by Turkish Cargo
According to the data announced for May by the WACD (World Air Cargo Data), the international air cargo information provider, Turkish Cargo, the global air cargo brand, increased its market share to 5 percent and transported 1 of every...
News
Amcor Research Provides Insights into Consumer Attitudes Towards Responsible Packaging
Global packaging leader Amcor published results from its latest research into consumer perceptions of sustainability and packaging. The proprietary insights give Amcor and its customers a unique understanding of evolving preferences, including a willingness to pay more for differentiated...
News
CURE Pharmaceutical Receives NSF cGMP Certification for Dietary Supplements
CURE Pharmaceutical, an innovative drug delivery and development company, announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This certification is issued only after extensive material and facility...
News
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
Boehringer Ingelheim and Numab Therapeutics announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects aiming at novel therapies for difficult-to-treat lung and gastrointestinal (GI) cancers and patients with geographic...
News
ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States
ILIAS Biologics Inc., a global leader in exosome-based therapeutics, announced that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).
A patent for ILIAS's exosome engineering was previously granted in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read